{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:01:29Z","timestamp":1791500489971,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.mayocp.2012.03.010","type":"journal-article","created":{"date-parts":[[2012,6,4]],"date-time":"2012-06-04T16:10:01Z","timestamp":1338826201000},"page":"581-586","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":135,"title":["Complications Associated With Use of Levamisole-Contaminated Cocaine: An Emerging Public Health Challenge"],"prefix":"10.1016","volume":"87","author":[{"given":"Kachiu C.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Ladizinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G.","family":"Federman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"49","key":"10.1016\/j.mayocp.2012.03.010_bib2","first-page":"1381","article-title":"Agranulocytosis associated with cocaine use\u2014four states, March 2008-November 2009","volume":"58","year":"2009","journal-title":"MMWR Morb Motal Wkly Rep"},{"key":"10.1016\/j.mayocp.2012.03.010_bib3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1477-7517-6-30","article-title":"Levamisole tainted cocaine causing severe neutropenia in Alberta and British Columbia","volume":"6","author":"Knowles","year":"2009","journal-title":"Harm Reduct J"},{"issue":"4","key":"10.1016\/j.mayocp.2012.03.010_bib4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.7326\/0003-4819-150-4-200902170-00102","article-title":"Agranulocytosis after consumption of cocaine adulterated with levamisole","volume":"150","author":"Zhu","year":"2009","journal-title":"Ann Intern Med"},{"issue":"1-3","key":"10.1016\/j.mayocp.2012.03.010_bib5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.forsciint.2011.06.027","article-title":"Analysis of illicit cocaine and heroin samples seized in Luxembourg from 2005-2010","volume":"212","author":"Schneider","year":"2011","journal-title":"Forensic Sci Int"},{"issue":"4","key":"10.1016\/j.mayocp.2012.03.010_bib6","first-page":"11","article-title":"Levamisole as a contaminant of illicit cocaine","volume":"16","author":"Morley","year":"2006","journal-title":"J Clandestine Lab Invest Chemists Assoc"},{"issue":"3-4","key":"10.1016\/j.mayocp.2012.03.010_bib9","first-page":"82","article-title":"Identification of levamisole impurities found in illicit cocaine exhibits","volume":"6","author":"Casale","year":"2008","journal-title":"Microgram J"},{"issue":"1","key":"10.1016\/j.mayocp.2012.03.010_bib10","first-page":"16","article-title":"Identification of levamisole and lidocaine acetylation reaction impurities found in heroin exhibits","volume":"8","author":"Casale","year":"2011","journal-title":"Microgram J"},{"issue":"8","key":"10.1016\/j.mayocp.2012.03.010_bib11","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1016\/S0041-1345(98)01370-0","article-title":"Comparative study of the clinical efficacy of four DMARDs (leflunomide, methotrexate, cyclosporine, and levamisole) in patients with rheumatoid arthritis","volume":"30","author":"Popovic","year":"1998","journal-title":"Transplant Proc"},{"issue":"suppl 5","key":"10.1016\/j.mayocp.2012.03.010_bib12","first-page":"81","article-title":"Immunological treatment of rheumatoid arthritis","volume":"8","author":"Sany","year":"1990","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"10.1016\/j.mayocp.2012.03.010_bib13","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/ard.47.12.995","article-title":"Scintimetric assessment of synovitis activity during treatment with disease modifying antirheumatic drugs","volume":"47","author":"Olsen","year":"1988","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.mayocp.2012.03.010_bib14","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00467-007-0708-7","article-title":"Short- and long-term efficacy of levamisole as adjunctive therapy in childhood nephrotic syndrome","volume":"23","author":"Boyer","year":"2008","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"10.1016\/j.mayocp.2012.03.010_bib15","first-page":"CD002290","article-title":"Non-corticosteroid treatment for nephrotic syndrome in children","author":"Durkan","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.mayocp.2012.03.010_bib16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00467-004-1615-9","article-title":"Levamisole in steroid-sensitive nephrotic syndrome of childhood: the lost paradise?","volume":"20","author":"Davin","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.mayocp.2012.03.010_bib17","series-title":"Textbook of Pharmacology","author":"Smith","year":"1992"},{"issue":"2","key":"10.1016\/j.mayocp.2012.03.010_bib18","first-page":"127","article-title":"Chemotactic function of polymorphonuclear leukocytes from patients with recurrent infections: partial correction by levamisole \u201cin vitro.\u201d","volume":"13","author":"Stein","year":"1985","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"4","key":"10.1016\/j.mayocp.2012.03.010_bib19","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/infdis\/138.4.437","article-title":"Enhancement of neutrophil chemotaxis and alteration of levels of cellular cyclic nucleotides by levamisole","volume":"138","author":"Hogan","year":"1978","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.mayocp.2012.03.010_bib20","first-page":"142","article-title":"Defective neutrophil motility and recurrent infection: in vitro and in vivo effects of levamisole","volume":"33","author":"Rabson","year":"1978","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"10.1016\/j.mayocp.2012.03.010_bib21","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1172\/JCI108716","article-title":"Effects of levamisole on normal and abnormal leukocyte locomotion","volume":"59","author":"Wright","year":"1977","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.mayocp.2012.03.010_bib22","doi-asserted-by":"crossref","first-page":"428","DOI":"10.4049\/jimmunol.117.2.428","article-title":"In vitro stimulation of neutrophil motility by levamisole: maintenance of cGMP levels in chemotactically stimulated levamisole-treated neutrophils","volume":"117","author":"Anderson","year":"1976","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.mayocp.2012.03.010_bib23","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1016\/j.jaad.2011.05.023","article-title":"Levamisole-induced thrombosis: literature review and pertinent laboratory findings","volume":"65","author":"Lee","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.mayocp.2012.03.010_bib24","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/j.jaad.2010.09.778","article-title":"ANCA-positive necrotizing vasculitis and thrombotic vasculopathy induced by levamisole-adulterated cocaine: a distinctive clinicopathologic presentation","volume":"65","author":"Jenkins","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.mayocp.2012.03.010_bib25","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.pediatrneurol.2010.11.020","article-title":"Epilepsia partialis continua associated with levamisole","volume":"44","author":"Aberastury","year":"2011","journal-title":"Pediatr Neurol"},{"issue":"suppl","key":"10.1016\/j.mayocp.2012.03.010_bib26","first-page":"S71","article-title":"Drug resistance and neurotransmitter receptors of nematodes: recent studies on the mode of action of levamisole","volume":"131","author":"Martin","year":"2005","journal-title":"Parasitology"},{"key":"10.1016\/j.mayocp.2012.03.010_bib27","unstructured":"Karch SB, Mari F, Bartolini V, Bertol E. Aminorex poisoning in cocaine abusers [published online ahead of print July 15, 2011]. Int J Cardiol. PMID: 21764154"},{"issue":"5","key":"10.1016\/j.mayocp.2012.03.010_bib28","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.jpba.2011.03.039","article-title":"Determination of aminorex in human urine samples by GC-MS after use of levamisole","volume":"55","author":"Bertol","year":"2011","journal-title":"J Pharm Biomed Anal"},{"issue":"2","key":"10.1016\/j.mayocp.2012.03.010_bib29","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/DAD.0b013e31821cc0bf","article-title":"Levamisole-induced vasculopathy: a report of 2 cases and a novel histopathologic finding","volume":"34","author":"Jacob","year":"2012","journal-title":"Am J Dermatopathol"},{"issue":"4","key":"10.1016\/j.mayocp.2012.03.010_bib30","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jaad.2010.08.024","article-title":"Characteristic purpura of the ears, vasculitis, and neutropenia\u2014a potential public health epidemic associated with levamisole-adulterated cocaine","volume":"65","author":"Chung","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.mayocp.2012.03.010_bib31","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.2215\/CJN.03440411","article-title":"Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease","volume":"6","author":"McGrath","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.mayocp.2012.03.010_bib32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/RHU.0b013e31820e6822","article-title":"Five consecutive cases of a cutaneous vasculopathy in users of levamisole-adulterated cocaine","volume":"17","author":"Ullrich","year":"2011","journal-title":"J Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.mayocp.2012.03.010_bib33","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jaad.2010.01.055","article-title":"Cocaine-associated retiform purpura and neutropenia: is levamisole the culprit?","volume":"63","author":"Waller","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.mayocp.2012.03.010_bib34","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1002\/art.30590","article-title":"Purpura, cutaneous necrosis, and antineutrophil cytoplasmic antibodies associated with levamisole-adulterated cocaine","volume":"63","author":"Graf","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.mayocp.2012.03.010_bib35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000329436","article-title":"Necrosis of ears after use of cocaine probably adulterated with levamisole","volume":"223","author":"de la Hera","year":"2011","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.mayocp.2012.03.010_bib36","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.0307-6938.2001.00944.x","article-title":"A boy with cutaneous necrosis occurring during treatment with levamisole","volume":"27","author":"Powell","year":"2002","journal-title":"Clin Exp Dermatol"},{"issue":"10","key":"10.1016\/j.mayocp.2012.03.010_bib37","first-page":"1204","article-title":"Levamisole induced necrosis of the skin and neutropenia following intranasal cocaine use: a newly recognized syndrome","volume":"10","author":"Mouzakis","year":"2011","journal-title":"J Drugs Dermatol"},{"issue":"9","key":"10.1016\/j.mayocp.2012.03.010_bib38","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1016\/j.leukres.2011.05.012","article-title":"Agranulocytosis in cocaine users in Ohio: suspected levamisole taint","volume":"35","author":"Herms","year":"2011","journal-title":"Leuk Res"},{"key":"10.1016\/j.mayocp.2012.03.010_bib39","unstructured":"Friend K, Milone MC, Perrone J. Hyponatremia associated with levamisole-adulterated cocaine use in emergency department patients [published online ahead of print September 27, 2011]. Ann Emerg Med. PMID: 21958733"},{"issue":"24","key":"10.1016\/j.mayocp.2012.03.010_bib40","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1056\/NEJMicm1008722","article-title":"Images in clinical medicine: toxic effects of levamisole in a cocaine user","volume":"364","author":"Muirhead","year":"2011","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.mayocp.2012.03.010_bib41","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/jama.2011.531","article-title":"Prevalence of levamisole in urine toxicology screens positive for cocaine in an inner-city hospital","volume":"305","author":"Buchanan","year":"2011","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.mayocp.2012.03.010_bib42","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1553-2712.2011.01202.x","article-title":"Levamisole exposure and hematologic indices in cocaine users","volume":"18","author":"Chai","year":"2011","journal-title":"Acad Emerg Med"},{"issue":"1","key":"10.1016\/j.mayocp.2012.03.010_bib43","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/BCR.0b013e318233fc64","article-title":"Levamisole-induced necrosis of skin, soft tissue, and bone: case report and review of literature","volume":"33","author":"Ching","year":"2012","journal-title":"J Burn Care Res"},{"issue":"2","key":"10.1016\/j.mayocp.2012.03.010_bib44","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2165\/00003088-198815020-00001","article-title":"Clinical pharmacokinetics of anthelmintic drugs","volume":"15","author":"Edwards","year":"1988","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"10.1016\/j.mayocp.2012.03.010_bib45","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/anatox\/35.3.176","article-title":"Detection of levamisole exposure in cocaine users by liquid chromatography-tandem mass spectrometry","volume":"35","author":"Lynch","year":"2011","journal-title":"J Anal Toxicol"},{"issue":"2","key":"10.1016\/j.mayocp.2012.03.010_bib46","first-page":"217","article-title":"Levamisole-induced retiform purpura","volume":"10","author":"Click","year":"2011","journal-title":"J Drugs Dermatol"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619612003904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619612003904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T23:49:48Z","timestamp":1675900188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619612003904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0025619612003904"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2012.03.010","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complications Associated With Use of Levamisole-Contaminated Cocaine: An Emerging Public Health Challenge","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2012.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}